世界のバイオモニタリング・バイオバーデン試験市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Biomonitoring and Bioburden Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0823
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、バイオモニタリング・バイオバーデン試験のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（培地・試薬キット、機器、PCR（ポリメラーゼ連鎖反応）、自動微生物同定システム、顕微鏡、その他）、用途別市場規模（医療機器試験、製造工程監視、環境監視）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・バイオモニタリング・バイオバーデン試験の市場動向
・企業の競争状況、市場シェア
・バイオモニタリング・バイオバーデン試験の種類別市場規模（培地・試薬キット、機器、PCR（ポリメラーゼ連鎖反応）、自動微生物同定システム、顕微鏡、その他）
・バイオモニタリング・バイオバーデン試験の用途別市場規模（医療機器試験、製造工程監視、環境監視）
・バイオモニタリング・バイオバーデン試験の北米市場規模2016-2027（アメリカ、カナダ）
・バイオモニタリング・バイオバーデン試験のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・バイオモニタリング・バイオバーデン試験のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・バイオモニタリング・バイオバーデン試験の中南米市場規模2016-2027（メキシコ、ブラジル）
・バイオモニタリング・バイオバーデン試験の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck、STERIS Laboratories、Charles River Laboratories International、Lumex Instruments、Pacific BioLabs、Sigma-Aldrich、WuXi AppTec、Dynatec Labs、Nelson Laboratories）
・結論

Biomonitoring is a simple process its of two type, the very first one is to check the toxic level before and after the project is completed and the other one is the proper checking of all the valid regulation and parameter for the project and maintained the guideline. Bioburden are refer as the number of bacteria present on the surface, the surface is not show sterilized. The present of bacteria on the surface can affect the industry like pharmaceutical and other industry which is directly related to the human begins. Various regulation has been made to check all the parameter of safety and cleaning in the industry or their products. For instance, in the U.S the Title 21 is the code of federal regulation that cover the drugs and food for FDA. Many other organization are also having the code and standard parameter for monitoring.
Biomonitoring and Bioburden testing market is a growing market, as there is growth in the pharmaceutical, biotechnology, medical devices, food industry and other industry every year and the guideline of the respective association are very strike for the industries. The product produce by this industry are directly or indirectly taken or affect the human. As the Centers for Disease Control and Prevention (U.S. Department of Health & Human Services) conduct by NBP (National Biomonitoring Program) which measure approx. 300 or more chemical and nutritional indicator in people. The costing and the approval process in various countries are the hindrance for this market.

Market Analysis and Insights: Global Biomonitoring and Bioburden Testing Market
The global Biomonitoring and Bioburden Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biomonitoring and Bioburden Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biomonitoring and Bioburden Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biomonitoring and Bioburden Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biomonitoring and Bioburden Testing market.

Global Biomonitoring and Bioburden Testing Scope and Market Size
Biomonitoring and Bioburden Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biomonitoring and Bioburden Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Culture Media and Reagents Kit
Instruments
PCR (Polymerase Chain Reaction)
Automated Microbial Identification Systems
Microscope
Others

Segment by Application
Medical Devices Testing
Monitoring of Manufacturing Process
Environmental Monitoring

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
STERIS Laboratories
Charles River Laboratories International
Lumex Instruments
Pacific BioLabs
Sigma-Aldrich
WuXi AppTec
Dynatec Labs
Nelson Laboratories

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomonitoring and Bioburden Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Culture Media and Reagents Kit
1.2.3 Instruments
1.2.4 PCR (Polymerase Chain Reaction)
1.2.5 Automated Microbial Identification Systems
1.2.6 Microscope
1.2.7 Others
1.3 Market by Application
1.3.1 Global Biomonitoring and Bioburden Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Medical Devices Testing
1.3.3 Monitoring of Manufacturing Process
1.3.4 Environmental Monitoring
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biomonitoring and Bioburden Testing Market Perspective (2016-2027)
2.2 Biomonitoring and Bioburden Testing Growth Trends by Regions
2.2.1 Biomonitoring and Bioburden Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biomonitoring and Bioburden Testing Historic Market Share by Regions (2016-2021)
2.2.3 Biomonitoring and Bioburden Testing Forecasted Market Size by Regions (2022-2027)
2.3 Biomonitoring and Bioburden Testing Industry Dynamic
2.3.1 Biomonitoring and Bioburden Testing Market Trends
2.3.2 Biomonitoring and Bioburden Testing Market Drivers
2.3.3 Biomonitoring and Bioburden Testing Market Challenges
2.3.4 Biomonitoring and Bioburden Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biomonitoring and Bioburden Testing Players by Revenue
3.1.1 Global Top Biomonitoring and Bioburden Testing Players by Revenue (2016-2021)
3.1.2 Global Biomonitoring and Bioburden Testing Revenue Market Share by Players (2016-2021)
3.2 Global Biomonitoring and Bioburden Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biomonitoring and Bioburden Testing Revenue
3.4 Global Biomonitoring and Bioburden Testing Market Concentration Ratio
3.4.1 Global Biomonitoring and Bioburden Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomonitoring and Bioburden Testing Revenue in 2020
3.5 Biomonitoring and Bioburden Testing Key Players Head office and Area Served
3.6 Key Players Biomonitoring and Bioburden Testing Product Solution and Service
3.7 Date of Enter into Biomonitoring and Bioburden Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biomonitoring and Bioburden Testing Breakdown Data by Type
4.1 Global Biomonitoring and Bioburden Testing Historic Market Size by Type (2016-2021)
4.2 Global Biomonitoring and Bioburden Testing Forecasted Market Size by Type (2022-2027)

5 Biomonitoring and Bioburden Testing Breakdown Data by Application
5.1 Global Biomonitoring and Bioburden Testing Historic Market Size by Application (2016-2021)
5.2 Global Biomonitoring and Bioburden Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biomonitoring and Bioburden Testing Market Size (2016-2027)
6.2 North America Biomonitoring and Bioburden Testing Market Size by Type
6.2.1 North America Biomonitoring and Bioburden Testing Market Size by Type (2016-2021)
6.2.2 North America Biomonitoring and Bioburden Testing Market Size by Type (2022-2027)
6.2.3 North America Biomonitoring and Bioburden Testing Market Size by Type (2016-2027)
6.3 North America Biomonitoring and Bioburden Testing Market Size by Application
6.3.1 North America Biomonitoring and Bioburden Testing Market Size by Application (2016-2021)
6.3.2 North America Biomonitoring and Bioburden Testing Market Size by Application (2022-2027)
6.3.3 North America Biomonitoring and Bioburden Testing Market Size by Application (2016-2027)
6.4 North America Biomonitoring and Bioburden Testing Market Size by Country
6.4.1 North America Biomonitoring and Bioburden Testing Market Size by Country (2016-2021)
6.4.2 North America Biomonitoring and Bioburden Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Biomonitoring and Bioburden Testing Market Size (2016-2027)
7.2 Europe Biomonitoring and Bioburden Testing Market Size by Type
7.2.1 Europe Biomonitoring and Bioburden Testing Market Size by Type (2016-2021)
7.2.2 Europe Biomonitoring and Bioburden Testing Market Size by Type (2022-2027)
7.2.3 Europe Biomonitoring and Bioburden Testing Market Size by Type (2016-2027)
7.3 Europe Biomonitoring and Bioburden Testing Market Size by Application
7.3.1 Europe Biomonitoring and Bioburden Testing Market Size by Application (2016-2021)
7.3.2 Europe Biomonitoring and Bioburden Testing Market Size by Application (2022-2027)
7.3.3 Europe Biomonitoring and Bioburden Testing Market Size by Application (2016-2027)
7.4 Europe Biomonitoring and Bioburden Testing Market Size by Country
7.4.1 Europe Biomonitoring and Bioburden Testing Market Size by Country (2016-2021)
7.4.2 Europe Biomonitoring and Bioburden Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biomonitoring and Bioburden Testing Market Size (2016-2027)
8.2 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Type
8.2.1 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Application
8.3.1 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Region
8.4.1 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biomonitoring and Bioburden Testing Market Size (2016-2027)
9.2 Latin America Biomonitoring and Bioburden Testing Market Size by Type
9.2.1 Latin America Biomonitoring and Bioburden Testing Market Size by Type (2016-2021)
9.2.2 Latin America Biomonitoring and Bioburden Testing Market Size by Type (2022-2027)
9.2.3 Latin America Biomonitoring and Bioburden Testing Market Size by Type (2016-2027)
9.3 Latin America Biomonitoring and Bioburden Testing Market Size by Application
9.3.1 Latin America Biomonitoring and Bioburden Testing Market Size by Application (2016-2021)
9.3.2 Latin America Biomonitoring and Bioburden Testing Market Size by Application (2022-2027)
9.3.3 Latin America Biomonitoring and Bioburden Testing Market Size by Application (2016-2027)
9.4 Latin America Biomonitoring and Bioburden Testing Market Size by Country
9.4.1 Latin America Biomonitoring and Bioburden Testing Market Size by Country (2016-2021)
9.4.2 Latin America Biomonitoring and Bioburden Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biomonitoring and Bioburden Testing Market Size (2016-2027)
10.2 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Type
10.2.1 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Application
10.3.1 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country
10.4.1 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Biomonitoring and Bioburden Testing Introduction
11.1.4 Merck Revenue in Biomonitoring and Bioburden Testing Business (2016-2021)
11.1.5 Merck Recent Development
11.2 STERIS Laboratories
11.2.1 STERIS Laboratories Company Details
11.2.2 STERIS Laboratories Business Overview
11.2.3 STERIS Laboratories Biomonitoring and Bioburden Testing Introduction
11.2.4 STERIS Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2016-2021)
11.2.5 STERIS Laboratories Recent Development
11.3 Charles River Laboratories International
11.3.1 Charles River Laboratories International Company Details
11.3.2 Charles River Laboratories International Business Overview
11.3.3 Charles River Laboratories International Biomonitoring and Bioburden Testing Introduction
11.3.4 Charles River Laboratories International Revenue in Biomonitoring and Bioburden Testing Business (2016-2021)
11.3.5 Charles River Laboratories International Recent Development
11.4 Lumex Instruments
11.4.1 Lumex Instruments Company Details
11.4.2 Lumex Instruments Business Overview
11.4.3 Lumex Instruments Biomonitoring and Bioburden Testing Introduction
11.4.4 Lumex Instruments Revenue in Biomonitoring and Bioburden Testing Business (2016-2021)
11.4.5 Lumex Instruments Recent Development
11.5 Pacific BioLabs
11.5.1 Pacific BioLabs Company Details
11.5.2 Pacific BioLabs Business Overview
11.5.3 Pacific BioLabs Biomonitoring and Bioburden Testing Introduction
11.5.4 Pacific BioLabs Revenue in Biomonitoring and Bioburden Testing Business (2016-2021)
11.5.5 Pacific BioLabs Recent Development
11.6 Sigma-Aldrich
11.6.1 Sigma-Aldrich Company Details
11.6.2 Sigma-Aldrich Business Overview
11.6.3 Sigma-Aldrich Biomonitoring and Bioburden Testing Introduction
11.6.4 Sigma-Aldrich Revenue in Biomonitoring and Bioburden Testing Business (2016-2021)
11.6.5 Sigma-Aldrich Recent Development
11.7 WuXi AppTec
11.7.1 WuXi AppTec Company Details
11.7.2 WuXi AppTec Business Overview
11.7.3 WuXi AppTec Biomonitoring and Bioburden Testing Introduction
11.7.4 WuXi AppTec Revenue in Biomonitoring and Bioburden Testing Business (2016-2021)
11.7.5 WuXi AppTec Recent Development
11.8 Dynatec Labs
11.8.1 Dynatec Labs Company Details
11.8.2 Dynatec Labs Business Overview
11.8.3 Dynatec Labs Biomonitoring and Bioburden Testing Introduction
11.8.4 Dynatec Labs Revenue in Biomonitoring and Bioburden Testing Business (2016-2021)
11.8.5 Dynatec Labs Recent Development
11.9 Nelson Laboratories
11.9.1 Nelson Laboratories Company Details
11.9.2 Nelson Laboratories Business Overview
11.9.3 Nelson Laboratories Biomonitoring and Bioburden Testing Introduction
11.9.4 Nelson Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2016-2021)
11.9.5 Nelson Laboratories Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biomonitoring and Bioburden Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Culture Media and Reagents Kit
Table 3. Key Players of Instruments
Table 4. Key Players of PCR (Polymerase Chain Reaction)
Table 5. Key Players of Automated Microbial Identification Systems
Table 6. Key Players of Microscope
Table 7. Key Players of Others
Table 8. Global Biomonitoring and Bioburden Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Biomonitoring and Bioburden Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Biomonitoring and Bioburden Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Biomonitoring and Bioburden Testing Market Share by Regions (2016-2021)
Table 12. Global Biomonitoring and Bioburden Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Biomonitoring and Bioburden Testing Market Share by Regions (2022-2027)
Table 14. Biomonitoring and Bioburden Testing Market Trends
Table 15. Biomonitoring and Bioburden Testing Market Drivers
Table 16. Biomonitoring and Bioburden Testing Market Challenges
Table 17. Biomonitoring and Bioburden Testing Market Restraints
Table 18. Global Biomonitoring and Bioburden Testing Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Biomonitoring and Bioburden Testing Market Share by Players (2016-2021)
Table 20. Global Top Biomonitoring and Bioburden Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomonitoring and Bioburden Testing as of 2020)
Table 21. Ranking of Global Top Biomonitoring and Bioburden Testing Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Biomonitoring and Bioburden Testing Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Biomonitoring and Bioburden Testing Product Solution and Service
Table 25. Date of Enter into Biomonitoring and Bioburden Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biomonitoring and Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Biomonitoring and Bioburden Testing Revenue Market Share by Type (2016-2021)
Table 29. Global Biomonitoring and Bioburden Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Biomonitoring and Bioburden Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Biomonitoring and Bioburden Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Biomonitoring and Bioburden Testing Revenue Market Share by Application (2016-2021)
Table 33. Global Biomonitoring and Bioburden Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Biomonitoring and Bioburden Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Biomonitoring and Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Biomonitoring and Bioburden Testing Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Biomonitoring and Bioburden Testing Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Biomonitoring and Bioburden Testing Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Biomonitoring and Bioburden Testing Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Biomonitoring and Bioburden Testing Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Biomonitoring and Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Biomonitoring and Bioburden Testing Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Biomonitoring and Bioburden Testing Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Biomonitoring and Bioburden Testing Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Biomonitoring and Bioburden Testing Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Biomonitoring and Bioburden Testing Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Biomonitoring and Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Biomonitoring and Bioburden Testing Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Biomonitoring and Bioburden Testing Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Biomonitoring and Bioburden Testing Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Biomonitoring and Bioburden Testing Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Biomonitoring and Bioburden Testing Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2022-2027) & (US$ Million)
Table 65. Merck Company Details
Table 66. Merck Business Overview
Table 67. Merck Biomonitoring and Bioburden Testing Product
Table 68. Merck Revenue in Biomonitoring and Bioburden Testing Business (2016-2021) & (US$ Million)
Table 69. Merck Recent Development
Table 70. STERIS Laboratories Company Details
Table 71. STERIS Laboratories Business Overview
Table 72. STERIS Laboratories Biomonitoring and Bioburden Testing Product
Table 73. STERIS Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2016-2021) & (US$ Million)
Table 74. STERIS Laboratories Recent Development
Table 75. Charles River Laboratories International Company Details
Table 76. Charles River Laboratories International Business Overview
Table 77. Charles River Laboratories International Biomonitoring and Bioburden Testing Product
Table 78. Charles River Laboratories International Revenue in Biomonitoring and Bioburden Testing Business (2016-2021) & (US$ Million)
Table 79. Charles River Laboratories International Recent Development
Table 80. Lumex Instruments Company Details
Table 81. Lumex Instruments Business Overview
Table 82. Lumex Instruments Biomonitoring and Bioburden Testing Product
Table 83. Lumex Instruments Revenue in Biomonitoring and Bioburden Testing Business (2016-2021) & (US$ Million)
Table 84. Lumex Instruments Recent Development
Table 85. Pacific BioLabs Company Details
Table 86. Pacific BioLabs Business Overview
Table 87. Pacific BioLabs Biomonitoring and Bioburden Testing Product
Table 88. Pacific BioLabs Revenue in Biomonitoring and Bioburden Testing Business (2016-2021) & (US$ Million)
Table 89. Pacific BioLabs Recent Development
Table 90. Sigma-Aldrich Company Details
Table 91. Sigma-Aldrich Business Overview
Table 92. Sigma-Aldrich Biomonitoring and Bioburden Testing Product
Table 93. Sigma-Aldrich Revenue in Biomonitoring and Bioburden Testing Business (2016-2021) & (US$ Million)
Table 94. Sigma-Aldrich Recent Development
Table 95. WuXi AppTec Company Details
Table 96. WuXi AppTec Business Overview
Table 97. WuXi AppTec Biomonitoring and Bioburden Testing Product
Table 98. WuXi AppTec Revenue in Biomonitoring and Bioburden Testing Business (2016-2021) & (US$ Million)
Table 99. WuXi AppTec Recent Development
Table 100. Dynatec Labs Company Details
Table 101. Dynatec Labs Business Overview
Table 102. Dynatec Labs Revenue in Biomonitoring and Bioburden Testing Business (2016-2021) & (US$ Million)
Table 103. Dynatec Labs Recent Development
Table 104. Nelson Laboratories Company Details
Table 105. Nelson Laboratories Business Overview
Table 106. Nelson Laboratories Biomonitoring and Bioburden Testing Product
Table 107. Nelson Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2016-2021) & (US$ Million)
Table 108. Nelson Laboratories Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biomonitoring and Bioburden Testing Market Share by Type: 2020 VS 2027
Figure 2. Culture Media and Reagents Kit Features
Figure 3. Instruments Features
Figure 4. PCR (Polymerase Chain Reaction) Features
Figure 5. Automated Microbial Identification Systems Features
Figure 6. Microscope Features
Figure 7. Others Features
Figure 8. Global Biomonitoring and Bioburden Testing Market Share by Application: 2020 VS 2027
Figure 9. Medical Devices Testing Case Studies
Figure 10. Monitoring of Manufacturing Process Case Studies
Figure 11. Environmental Monitoring Case Studies
Figure 12. Biomonitoring and Bioburden Testing Report Years Considered
Figure 13. Global Biomonitoring and Bioburden Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Biomonitoring and Bioburden Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Biomonitoring and Bioburden Testing Market Share by Regions: 2020 VS 2027
Figure 16. Global Biomonitoring and Bioburden Testing Market Share by Regions (2022-2027)
Figure 17. Global Biomonitoring and Bioburden Testing Market Share by Players in 2020
Figure 18. Global Top Biomonitoring and Bioburden Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomonitoring and Bioburden Testing as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Biomonitoring and Bioburden Testing Revenue in 2020
Figure 20. Global Biomonitoring and Bioburden Testing Revenue Market Share by Type (2016-2021)
Figure 21. Global Biomonitoring and Bioburden Testing Revenue Market Share by Type (2022-2027)
Figure 22. North America Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Biomonitoring and Bioburden Testing Market Share by Type (2016-2027)
Figure 24. North America Biomonitoring and Bioburden Testing Market Share by Application (2016-2027)
Figure 25. North America Biomonitoring and Bioburden Testing Market Share by Country (2016-2027)
Figure 26. United States Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Biomonitoring and Bioburden Testing Market Share by Type (2016-2027)
Figure 30. Europe Biomonitoring and Bioburden Testing Market Share by Application (2016-2027)
Figure 31. Europe Biomonitoring and Bioburden Testing Market Share by Country (2016-2027)
Figure 32. Germany Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Biomonitoring and Bioburden Testing Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Biomonitoring and Bioburden Testing Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Biomonitoring and Bioburden Testing Market Share by Region (2016-2027)
Figure 42. China Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Biomonitoring and Bioburden Testing Market Share by Type (2016-2027)
Figure 50. Latin America Biomonitoring and Bioburden Testing Market Share by Application (2016-2027)
Figure 51. Latin America Biomonitoring and Bioburden Testing Market Share by Country (2016-2027)
Figure 52. Mexico Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Biomonitoring and Bioburden Testing Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Biomonitoring and Bioburden Testing Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Biomonitoring and Bioburden Testing Market Share by Country (2016-2027)
Figure 58. Turkey Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Biomonitoring and Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Merck Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2016-2021)
Figure 62. STERIS Laboratories Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2016-2021)
Figure 63. Charles River Laboratories International Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2016-2021)
Figure 64. Lumex Instruments Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2016-2021)
Figure 65. Pacific BioLabs Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2016-2021)
Figure 66. Sigma-Aldrich Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2016-2021)
Figure 67. WuXi AppTec Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2016-2021)
Figure 68. Dynatec Labs Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2016-2021)
Figure 69. Nelson Laboratories Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Global Biomonitoring and Bioburden Testing Market Size, Status and Forecast 2021-2027
QYR2104Z0823 2021年4月 92Pages
QYResearch社発行の本調査資料では、バイオモニタリング・バイオバーデン試験のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（培地・試薬キット、機器、PCR（ポリメラーゼ連鎖反応）、自動微生物同定システム、顕微鏡、その他）、用途別市場規模（...

世界のバイオバーデン試験市場規模・現状・予測（2021年-2027年）

Global Bioburden Testing Market Size, Status and Forecast 2021-2027
QYR2104Z0775 2021年4月 94Pages
QYResearch社発行の本調査資料では、バイオバーデン試験のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器、消耗品）、用途別市場規模（製薬、バイオテクノロジー、CMO）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界のバイオバーデン試験装置市場 2021：企業別、地域別、種類・用途別

Global Bioburden Testing Instrument Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z02181 2021年4月 100Pages
当調査資料では、バイオバーデン試験装置のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。バイオバーデン試験装置の種類別市場規模（膜ろ過法、プレートカウント法）、用途別市場規模（医薬品、食品・飲料、マイクロエレクトロニクス、その他）、地域別市場規模（北米、...

世界の血液検査市場規模・現状・予測（2021年-2027年）

Global Blood Testing Market Size, Status and Forecast 2021-2027
QYR2104Z0910 2021年4月 92Pages
QYResearch社発行の本調査資料では、血液検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ブドウ糖、脂質、BUN、A1C、CRP、ビタミンD、ALT、AST、甲状腺刺激ホルモン）、用途別市場規模（病院、クリニック・診断センター、その他...

世界の薬物乱用検査サービス市場規模・現状・予測（2021年-2027年）

Global Drug of Abuse Testing Services Market Size, Status and Forecast 2021-2027
QYR2104Z1989 2021年4月 92Pages
QYResearch社発行の本調査資料では、薬物乱用検査サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アルコール、大麻、コカイン、オピオイド、アンフェタミン、LSD、その他）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模...

世界のトキソプラズマ症検査市場規模・現状・予測（2021年-2027年）

Global Toxoplasmosis Testing Market Size, Status and Forecast 2021-2027
QYR2104Z5691 2021年4月 90Pages
QYResearch社発行の本調査資料では、トキソプラズマ症検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（検査装置、試薬消耗品）、用途別市場規模（病院、商業＆私立研究所、医師用オフィス）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の梅毒検査市場規模・現状・予測（2021年-2027年）

Global Syphilis Testing Market Size, Status and Forecast 2021-2027
QYR2104Z5535 2021年4月 90Pages
QYResearch社発行の本調査資料では、梅毒検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（一次梅毒、二次梅毒）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南...

世界のHPV検査市場規模・現状・予測（2021年-2027年）

Global HPV Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2934 2021年4月 99Pages
QYResearch社発行の本調査資料では、HPV検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HPV検査、フォローアップHPV検査、共同検査）、用途別市場規模（子宮頸がん検診、膣がん検診、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界のヘモグロビン検査市場規模・現状・予測（2021年-2027年）

Global Hemoglobin Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2769 2021年4月 91Pages
QYResearch社発行の本調査資料では、ヘモグロビン検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クロマトグラフィー、イムノアッセイ）、用途別市場規模（病院、研究センター、研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の梅毒検査市場規模・現状・予測（2021年-2027年）

世界のバイオモニタリング・バイオバーデン試験市場規模・現状・予測（2021年-2027年） Biomonitoring is a simple process its of two type, the very first one is to check the toxic level before and after the project is completed and the other one is the proper checking of all the valid regulation and parameter for the project and maintained the guideline. Bioburden are refer as the numb…
世界のバイオバーデン試験市場規模・現状・予測（2021年-2027年） Bioburden testing is a process of measuring viable microorganisms on medical devices, raw material, or package. The process helps in determining parameters for its sterilization process to ensure safety and effectiveness of medical devices. Market Analysis and Insights: Global Bioburden Testing Mark…
世界のバイオバーデン試験装置市場 2021：企業別、地域別、種類・用途別 The Bioburden Testing Instrument market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
世界の細菌同定・薬剤感受性試験市場規模・現状・予測（2021年-2027年） Susceptibility is a term used when microbe such as bacteria and fungi are unable to grow in the presence of one or more antimicrobial drugs. Susceptibility testing is performed on bacteria or fungi causing an individual's infection after they have been recovered in a culture of the specimen. Bacteri…
世界のポリメラーゼ連鎖反応（PCR）市場規模・現状・予測（2021年-2027年） Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials. Market Analysis and Insights: Global Polymerase Chain Reaction…